Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: ASE
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Optiscan Imaging Ltd

+ Add to Watchlist

OIL:AU

0.0590 AUD 0.00000.00%

As of 01:59:35 ET on 04/24/2015.

Snapshot for Optiscan Imaging Ltd (OIL)

Open: 0.0590 Day's Range: 0.0570 - 0.0590 Volume: 193,608
Previous Close: 0.0590 52wk Range: 0.0280 - 0.1900 1-Yr Rtn: +18.00%

Stock Chart for OIL

No chart data available.
  • OIL:AU 0.0590
  • 1D
  • 1M
  • 1Y
0.0590
Interactive OIL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OIL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0059
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 12.21
Shares Outstanding (M) 207.02
30 Day Average Volume 575,190
Price/Book (mrq) 293.7356
Price/Sale (ttm) 139.9673
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OIL

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for OIL

Optiscan Imaging Limited is a proprietor of patents which enable a confocal microscope to be miniaturized to the point where a confocal endomicroscope is made possible. The process enables living tissue to be examined non-invasively at a cellular level, opening up the possibilities for non-invasive disease monitoring and diagnosis.

Angus Matthew HoltChairmanBruce Richard AndrewCFO/Secretary
Peter Maxwell DelaneyDirector:Technology
More Company Profile & Key Executives for OIL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil